MediWound (MDWD) Change in Account Payables (2013 - 2026)
MediWound (MDWD) posted quarterly Change in Account Payables of -$59000.0 for Q4 2025, down 102.51% year-over-year from $2.4 million in Q4 2024, and down 103.43% quarter-over-quarter from $1.7 million in Q3 2025.
MediWound (MDWD) Change in Account Payables (2013 - 2026) Analysis & Trends
MediWound's Change in Account Payables history runs 13 years deep, the most recent figure standing at -$59000.0 for Q4 2025.
- In Q4 2025, Change in Account Payables fell 102.51% year-over-year to -$59000.0; the TTM figure through Dec 2025 stood at $2.4 million (up 478.82% YoY), while the FY2025 annual figure was $2.4 million, up 478.82% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$59000.0, down from $1.7 million in the prior quarter.
- The five-year high for Change in Account Payables was $2.4 million in Q4 2024, with the low at -$1.4 million in Q1 2024.
- The 5-year median for Change in Account Payables is $277500.0 (2021), against an average of $277800.0.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables plunged 720.36% in 2024, then jumped 3679.17% in 2025.
- MediWound's Change in Account Payables stood at $990000.0 in 2021, then slipped by 20.81% to $784000.0 in 2022, then soared by 39.41% to $1.1 million in 2023, then jumped by 115.37% to $2.4 million in 2024, then tumbled by 102.51% to -$59000.0 in 2025.
- Business Quant data shows MDWD's Change in Account Payables at -$59000.0 in Q4 2025, $1.7 million in Q3 2025, and $794000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | 37,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37,000.00 |
| Jun 30, 2026 | 37,000.00 |
| Dec 31, 2025 | -59,000.00 |
| Dec 31, 2025 | -59,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 794,000.00 |
| Jun 30, 2025 | 794,000.00 |
| Mar 31, 2025 | -103,000.00 |
| Mar 31, 2025 | -103,000.00 |
| Dec 31, 2024 | 2.35 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Sep 30, 2024 | -48,000.00 |
| Sep 30, 2024 | -48,000.00 |
| Jun 30, 2024 | -530,000.00 |
| Jun 30, 2024 | -530,000.00 |
| Mar 31, 2024 | -1.37 Mn |
| Mar 31, 2024 | -1.37 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2023 | 1.09 Mn |